Coegin Pharma AB (NGM:COEGIN)

Sweden flag Sweden · Delayed Price · Currency is SEK
3.200
+0.130 (4.23%)
At close: Jun 27, 2025
-54.29%
Market Cap 89.31M
Revenue (ttm) n/a
Net Income (ttm) -22.83M
Shares Out 24.88M
EPS (ttm) -1.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 33,524
Average Volume 25,755
Open n/a
Previous Close 3.070
Day's Range n/a
52-Week Range 3.200 - 8.300
Beta 0.93
RSI 52.73
Earnings Date Jul 29, 2025

About Coegin Pharma AB

Coegin Pharma AB, a biotechnology company, engages in developing peptide-based products for hair growth and skin pigmentation in Sweden. The company develops Follicopeptide, a peptide designed to enhance hair growth; and NPP-4, a natural pigmentation peptide 4 works by facilitating the transport of melanin to the skin, mimicking the natural process that occurs during sun exposure or tanning beds. It is also developing FOL026, a drug candidate which is in preclinical trial for the treatment of myocardial infarction; AVX420, a drug candidate whic... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 1
Stock Exchange Nordic Growth Market
Ticker Symbol COEGIN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.